Aortic aneurysm is a life-threatening complication that may be associated with Avelox and other fluoroquinolone antibiotics. One recent study suggests that patients taking these drugs may face double the risk for an aortic aneurysm in the months after treatment is initiated.
Fluoroquinolone antibiotics are known to be associated with a number of serious side effects, ranging from heart rhythm disturbances to peripheral neuropathy. Some of these complications, such as tendon injuries and ruptures, are thought to be associated with collagen degradation. Now, research is suggesting that collagen degradation related to the use of fluoroquinolones may extend to the collagen that lines the walls of the aorta. Such a phenomenon could increase a patient’s risk for aortic aneurysm and aortic dissection.
Two studies published in 2015 reported a potential link between the use of drugs like Avelox and aortic aneurysm:
The aorta is the major artery in the body. It is the pathway by which oxygen-rich blood makes its way from the heart to the rest of the body. An aneurysm is the excessive localized enlargement of an artery caused by a weakening of the artery wall.
An aortic aneurysm that occurs around the stomach is called an abdominal aortic aneurysm. Symptoms include:
A thoracic aortic aneurysm occurs in the chest area. Symptoms include:
If an aortic aneurysm ruptures, death can quickly follow. Symptoms of a rupture include:
Avelox users who suffered an aortic aneurysm while using this antibiotic may be eligible for compensation. To learn more about filing an Avelox lawsuit, please call (888) 994-5118 to discuss your case with an attorney at Bernstein Liebhard LLP.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.